Surgery may boost survival in rare vascular disease
NCT ID NCT07149805
Summary
This study looked back at 78 patients with severe Takayasu arteritis, a rare inflammatory disease that damages the body's largest arteries. Researchers compared whether surgery or medication alone led to better survival rates. The goal was to understand which approach helps patients with severe artery narrowing live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TAKAYASU ARTERITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.